In high income countries, the implementation of routine and opportunistic screening for prostate cancer in asymptomatic men by prostate specific antigen (PSA) testing has been a major factor causing the very high survival currently observed, with much of the longer survival times being a consequence of the so called lead-time bias introduced through over-diagnosis of indolent cancers [36]. The gene discussed is KLK3; the disease is prostate cancer.